|
|
||||||||
Clinical Chemistry, Vol 37, 742-747, Copyright © 1991 by American Association for Clinical Chemistry
D Brustolin, M Maierna, F Aguzzi, F Zoppi, G Tarenghi and G Berti
Research & Development Laboratory and Scientific Department, Bayer Diagnostici SpA, Milan, Italy.
A simple immunoturbidimetric method for quantifying apolipoproteins (apo) A-I and B in serum or plasma is described. A special reagent formulation, including large amounts of suitable detergents, obviates the need for a sample blank even with grossly lipemic specimens. The assay is rapid, easily automated, and thus convenient for routine work. For both apo A-I and apo B, the assay range is about 0.2-3.5 g/L. The performance characteristics were assessed with discrete (Optimate and Olli CD) and centrifugal analyzers (Cobas Fara and IL Monarch 2000). Average analytical recovery was 101.5% for apo A-I and 99.4% for apo B. Dilution tests showed found/expected ratios of 101.2% (apo A-I) and 101.0% (apo B). Overall precision (CV) ranged from 1.4% to 3.3% for apo A-I and from 1.1% to 8.3% for apo B. Comparisons with commercially available rate nephelometry, radial immunodiffusion, and immunoturbidimetric methods gave good correlations (r greater than or equal to 0.938). Using the immunoturbidimetric method, we also established the relationships between apolipoproteins and lipids and determined the reference intervals. We conclude that the proposed method is suitable for routine use in clinical laboratories.
The following articles in journals at HighWire Press have cited this article:
![]() |
F. Moloney, T.-P. Yeow, A. Mullen, J. J Nolan, and H. M Roche Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus Am. J. Clinical Nutrition, October 1, 2004; 80(4): 887 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Manning, A. Allum, S. Jones, W. H. F. Sutherland, and S. M. Williams The Effect of Hormone Replacement Therapy on Cardiovascular Risk Factors in Type 2 Diabetes: A Randomized Controlled Trial Arch Intern Med, July 23, 2001; 161(14): 1772 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Lewis-Barned, W. H. F. Sutherland, R. J. Walker, H. L. Walker, S. A. de Jong, E. A. Edwards, and V. H. Markham Plasma Cholesterol Esterification And Transfer, the Menopause, And Hormone Replacement Therapy in Women J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3534 - 3538. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. F. Sutherland, R. J. Walker, S. A. de Jong, A. M. van Rij, V. Phillips, and H. L. Walker Reduced Postprandial Serum Paraoxonase Activity After a Meal Rich in Used Cooking Fat Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1340 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. A. Williams, W. H. F. Sutherland, M. P. McCormick, S. A. de Jong, R. J. Walker, and G. T. Wilkins Impaired endothelial function following a meal rich in used cooking fat J. Am. Coll. Cardiol., March 15, 1999; 33(4): 1050 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. F. Sutherland, N. J. Restieaux, E. R. Nye, M. J. A. Williams, S. A. de Jong, M. C. Robertson, and H. L. Walker IDL Composition and Angiographically Determined Progression of Atherosclerotic Lesions During Simvastatin Therapy Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 577 - 583. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |